Prodrug nanoparticles potentiate tumor chemo-immunometabolic therapy by disturbing oxidative stress
出版年份 2022 全文链接
标题
Prodrug nanoparticles potentiate tumor chemo-immunometabolic therapy by disturbing oxidative stress
作者
关键词
-
出版物
JOURNAL OF CONTROLLED RELEASE
Volume 352, Issue -, Pages 909-919
出版商
Elsevier BV
发表日期
2022-11-15
DOI
10.1016/j.jconrel.2022.11.011
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer
- (2022) Lanxiang Huang et al. Molecular Cancer
- Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy
- (2022) Shuyan Han et al. Bioactive Materials
- Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment
- (2022) Yunlong Shan et al. Acta Pharmaceutica Sinica B
- Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer
- (2021) Fang Sun et al. Advanced Science
- Immune cell - produced ROS and their impact on tumor growth and metastasis
- (2021) Kilian B. Kennel et al. Redox Biology
- An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway
- (2021) Xiaomeng Ren et al. Acta Biomaterialia
- Epigenetic Remodeling Hydrogel Patches for Multidrug‐Resistant Triple‐Negative Breast Cancer
- (2021) Xiaoyuan Ji et al. ADVANCED MATERIALS
- MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination
- (2021) Xiaofang Wu et al. Journal for ImmunoTherapy of Cancer
- Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer
- (2021) Qingxin Mu et al. Materials Today
- Nanomedicines modulating myeloid-derived suppressor cells for improving cancer immunotherapy
- (2021) Xinghang Dai et al. Nano Today
- Recent advances on endogenous/exogenous stimuli-triggered nanoplatforms for enhanced chemodynamic therapy
- (2021) Qianqian Sun et al. COORDINATION CHEMISTRY REVIEWS
- Advances and perspectives in organic sonosensitizers for sonodynamic therapy
- (2021) Xuejian Xing et al. COORDINATION CHEMISTRY REVIEWS
- Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma
- (2020) Handan Xiang et al. Cancer Immunology Research
- The future of cancer immunotherapy: microenvironment-targeting combinations
- (2020) Yonina R. Murciano-Goroff et al. CELL RESEARCH
- Nanoparticle mediated cancer immunotherapy
- (2020) Jyoti Gupta et al. SEMINARS IN CANCER BIOLOGY
- rs11046147 mutation in the promoter region of lactate dehydrogenase‐B as a potential predictor of prognosis in triple‐negative breast cancer
- (2020) Jia Liu et al. Cancer Communications
- Pharmacological suppression of B7-H4 glycosylation restores antitumor immunity in immune-cold breast cancers
- (2020) Xinxin Song et al. Cancer Discovery
- The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses
- (2020) Tania Løve Aaes et al. CELL DEATH AND DIFFERENTIATION
- Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets
- (2020) Yue Gong et al. Cell Metabolism
- Understanding the tumor microenvironment for effective immunotherapy
- (2020) Habib Sadeghi Rad et al. MEDICINAL RESEARCH REVIEWS
- Targeting immunogenic cell death in cancer
- (2020) Asma Ahmed et al. Molecular Oncology
- Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer
- (2020) Fengqi Zhou et al. Nano Today
- The progress and perspective of strategies to improve tumor penetration of nanomedicines
- (2020) Jiang Hu et al. CHINESE CHEMICAL LETTERS
- Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling
- (2019) Minhong Shen et al. CANCER CELL
- Epigenetic drugs and their molecular targets in testicular germ cell tumours
- (2019) Sina Jostes et al. Nature Reviews Urology
- 192PPredictive role of derived neutrophil to lymphocyte ratio on platinum-based chemotherapy in triple-negative breast cancer
- (2019) A Marra et al. ANNALS OF ONCOLOGY
- Reactive Oxygen Species (ROS)-Based Nanomedicine
- (2019) Bowen Yang et al. CHEMICAL REVIEWS
- Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease
- (2019) M. Hanief Sofi et al. JOURNAL OF CLINICAL INVESTIGATION
- A positive feedback loop between Myc and aerobic glycolysis sustains tumor growth in a Drosophila tumor model
- (2019) Kenneth Kin Lam Wong et al. eLife
- Development and application of hyaluronic acid in tumor targeting drug delivery
- (2019) Zhijian Luo et al. Acta Pharmaceutica Sinica B
- Amplified Cancer Immunotherapy of a Surface-Engineered Antigenic Microparticle Vaccine by Synergistically Modulating Tumor Microenvironment
- (2019) Hongjuan Zhao et al. ACS Nano
- Intra/Extracellular Lactic Acid Exhaustion for Synergistic Metabolic Therapy and Immunotherapy of Tumors
- (2019) Fan Gao et al. ADVANCED MATERIALS
- Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast Cancers
- (2019) Lv Chen et al. ADVANCED MATERIALS
- Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
- (2019) Wendy Mao et al. Journal for ImmunoTherapy of Cancer
- Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer
- (2019) Ang Gao et al. NANO LETTERS
- Targeting bromodomain and extraterminal proteins in breast cancer
- (2018) Jennifer M. Sahni et al. PHARMACOLOGICAL RESEARCH
- Personalized Cancer Immunotherapy: Personalized Cancer Immunotherapy via Transporting Endogenous Tumor Antigens to Lymph Nodes Mediated by Nano Fe3 O4 (Small 38/2018)
- (2018) Binghua Wang et al. Small
- Modulating ROS to overcome multidrug resistance in cancer
- (2018) Qingbin Cui et al. DRUG RESISTANCE UPDATES
- The roles of sirtuins family in cell metabolism during tumor development
- (2018) Shunqin Zhu et al. SEMINARS IN CANCER BIOLOGY
- Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma
- (2016) K. Tateishi et al. CLINICAL CANCER RESEARCH
- Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment
- (2016) Xinfeng Chen et al. Oxidative Medicine and Cellular Longevity
- Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
- (2016) Qian Chen et al. Nature Communications
- BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
- (2016) Hengrui Zhu et al. Cell Reports
- SIRT3 Controls Cancer Metabolic Reprogramming by Regulating ROS and HIF
- (2011) Paul T. Schumacker CANCER CELL
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells
- (2009) Dong-yun Shi et al. Molecular Cancer
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started